Propyl-Thiocil

Quick links to important sections

Propyl-Thiocil

Method of action: Antithyroid, Thyroid Therapy

Treatment option: Hyperthyroidism, Thyrotoxicosis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Propyl-Thiocil

This section provides a concise overview of the drug's identity, composition, and general purpose, strictly avoiding details on dosage, usage instructions, side effects, or specific medical conditions.

Property Description
Active ingredient Propylthiouracil (PTU)
Form Oral tablets
Pharmacological class Antithyroid Agent (Thioamide Derivative)
General Purpose To normalize metabolism by reducing thyroid hormone production
Origin Synthetic Compound

What Type of Medicine is Propyl-Thiocil? (Identity and Classification)

Propyl-Thiocil is a prescription-only medication defined by its active component, Propylthiouracil (PTU), which is a synthetic compound used specifically for modulating the function of the thyroid gland. It is classified as an antithyroid agent, belonging to the thioamide pharmacological group, which addresses conditions of hormonal overactivity. The drug's formal chemical identity and classification relate to its role in treating the excessive amounts of thyroid hormone produced by the body. Consequently, its primary role is to act as a thyrostatic drug.


Propylthiouracil: Composition, Form, and General Purpose

The core composition of the medicine is the molecule Propylthiouracil, a single-active-ingredient heterocyclic compound supplied as oral tablets for oral administration. This substance is categorized as a Group H03B antithyroid preparation. This classification highlights the drug's established use in managing thyroid gland activity. Its overall general therapeutic purpose is to control the underlying mechanism of hormonal excess, thereby helping to alleviate the general physiological burden associated with an uncontrolled, overactive thyroid.


Distinguishing Features of Propylthiouracil

The primary action of Propylthiouracil is thyroid hormone synthesis inhibition, where it blocks the enzymes necessary for hormone production within the gland. Unlike some related antithyroid drugs, Propylthiouracil has the added feature of inhibiting the conversion of the less active T4 into the more potent T3 hormone in peripheral tissues. This secondary action, which is recognized for its effect on available active hormone, provides a key distinction in its pharmacological profile, influencing its specialized use as a thyrostatic drug in specific patient groups.

Regulatory References

  1. MedlinePlus, Propylthiouracil
  2. ATA, Thyroid Clinical Guidelines

What side effects are possible with Propyl-Thiocil?

Possible Side Effects and Safety Information

The safety profile of Propylthiouracil (Propyl-Thiocil) is defined by its officially documented adverse reactions, classified according to seriousness and the physiological system affected.

Serious Adverse Reactions

The most critical safety risks identified in official regulatory labeling are the potential for severe hepatic injury and agranulocytosis. Severe hepatic injury, including acute liver failure, necessitates particular attention and has been documented in both adult and pediatric patients. Agranulocytosis, a severe reduction in white blood cells, is formally classified as a rare adverse reaction. This hematologic effect typically manifests within the first 3 months of treatment.

Other serious adverse events include ANCA-associated vasculitis (inflammation of blood vessels) and severe skin reactions such as Stevens-Johnson Syndrome (SJS).

Common Adverse Reactions and System-Organ Effects

Adverse effects are broadly categorized by the affected system. Dermatological effects include rash, hives (urticaria), and hair loss (alopecia). Musculoskeletal complaints often involve joint pain (arthralgia) and muscle pain (myalgia). Gastrointestinal reactions commonly reported are nausea, vomiting, and a change in the sense of taste.

Safety Considerations for Specific Populations

Official documents highlight differing risks in certain groups. Pediatric patients are noted to have a higher risk of severe liver injury compared to adults. Use during pregnancy is associated with risks of fetal goiter, fetal hypothyroidism, and potential maternal liver problems. Additionally, as an antithyroid agent, the development of hypothyroidism is a documented adverse outcome that requires monitoring.

Overdose and Emergency Response

Overdose and When to Seek Help

A suspected overdose of Propyl-Thiocil (Propylthiouracil) requires immediate attention from emergency medical services. Regulators mandate contacting a poison control center or seeking immediate hospital care for any acute overdose scenario, particularly if an individual collapses, experiences a seizure, or has difficulty breathing. Immediate medical help is required for any suspected over-exposure.

Documented Manifestations and Severe Risks

Overdose manifestations officially documented in prescribing information may include acute signs such as nausea, vomiting, epigastric distress, headache, fever, and joint pain (arthralgia). The most severe potential adverse effect of acute toxicity is the development of agranulocytosis (a serious blood disorder), along with rare but serious outcomes such as hepatitis and exfoliative dermatitis. Repeated over dosage is specifically linked to the induction of goitre (thyroid enlargement) and a state of hypothyroidism.

Official Management and Monitoring

The official regulatory profile confirms that no specific antidote is known for Propylthiouracil toxicity. Management involves general symptomatic and supportive measures, including minimizing drug absorption through procedures like gastric lavage or the administration of activated charcoal. Due to the high risk of hematological complications, a full blood analysis and monitoring for signs of bone marrow depression are required following an overdose. Additionally, overdosage during pregnancy is noted as a specific risk for congenital goiter and hypothyroidism in the fetus.

Therapeutic Uses of Propyl-Thiocil

What Propyl-Thiocil Treats: Main Uses and Benefits

Propyl-Thiocil (Propylthiouracil) is primarily used to address the conditions and resulting symptom clusters associated with an overactive thyroid gland (hyperthyroidism), and is used to support efforts toward achieving a stable metabolic state. Its role involves addressing conditions marked by an excess of thyroid hormone.

This medication is commonly used in managing core endocrine conditions such as Graves' disease, Toxic Multinodular Goiter, and the acute and severe Thyrotoxic Crisis (Thyroid Storm).

Propyl-Thiocil is applied in addressing symptoms related to heightened physiological activity that arise from hormonal excess. This includes easing symptoms of nervousness, persistent anxiety, fine tremors (shakiness), rapid heart rates (tachycardia), and difficulty sleeping. It offers symptomatic relief that helps ease the overall symptom load.

“The treatment supports patients by addressing symptoms of increased neurological or muscular activity related to the condition.”

In clinical practice, this medication is applied in specific scenarios, such as when alternative symptomatic support is appropriate, or for hyperthyroidism management during the first trimester of pregnancy, or to prepare patients for thyroidectomy or radioactive iodine therapy. Its use is relevant when short-term symptom stabilization is important prior to these definitive procedures.

Quick Fact: Relief for Neurological Overdrive and Cardiovascular Symptoms

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Propyl-Thiocil?

Propyl-Thiocil (Propylthiouracil) eligibility is strictly defined by regulatory guidelines, restricting use primarily due to the risk of severe liver injury.


Contraindications and Reserved Use

Absolute Prohibition: The medicine must not be used by patients who have a known hypersensitivity to Propylthiouracil or who have a prior history of serious drug-induced reactions, such as agranulocytosis or severe hepatitis.

Reserved Use: For most adults with hyperthyroidism, use is reserved. It is authorized primarily for those who are intolerant of methimazole and for whom definitive treatments like surgery or radioactive iodine are not suitable. Use is strictly limited in patients with existing liver impairment due to the high risk of severe, fatal liver injury.


Age and Physiological Limitations

Pediatric Patients: Use is generally not recommended for children and adolescents due to the associated severe liver risks. It is highly restricted to rare instances where no other treatment option is viable.

Pregnancy and Lactation: Propyl-Thiocil may be the preferred agent during the first trimester of pregnancy. However, regulatory guidance suggests switching to an alternative during the second and third trimesters to minimize the risk of maternal liver toxicity. Older adults require cautious consideration due to potential reduced organ function.

What should I know about interactions with other medicines?

Propyl-Thiocil (Propylthiouracil) may interact with certain other medicines, affecting how they work or increasing the risk of specific side effects. It is essential for patients to inform their healthcare provider of all prescription drugs, over-the-counter products, vitamins, and herbal supplements they are currently taking.

Documented Drug Interactions

Interacting Product Category Potential Effect and Management
Oral Anticoagulants (e.g., Warfarin) Propyl-Thiocil may increase the anticoagulant effect, potentially due to interference with Vitamin K activity. The risk of bleeding may be heightened. Careful monitoring of blood clotting tests, such as Prothrombin Time (PT/INR), is required, and dose adjustments may be needed.
Sodium Iodide I-131 (Radio-iodine) This combination is generally contraindicated as Propyl-Thiocil can decrease the thyroid gland's uptake of radioactive iodine, reducing the effectiveness of the I-131 treatment. Antithyroid medicines must typically be discontinued for several days before I-131 administration.
Medications Causing Agranulocytosis Concurrent use with other drugs known to potentially lower white blood cell counts (agranulocytosis) may increase this risk. Close monitoring for signs of infection is necessary.
Beta-Adrenergic Blocking Agents As thyroid function normalizes, the body's clearance of beta-blockers (used for heart rate control or other conditions) may change. A reduced dose of the beta-blocker may become necessary to prevent unwanted effects.
Digitalis Glycosides (e.g., Digoxin) As the patient becomes euthyroid, serum levels of digitalis may increase, necessitating a reduced dose to prevent toxicity.

Mechanism of Action

How Propyl-Thiocil Works

Propyl-Thiocil (Propylthiouracil) engages two primary enzymatic pathways to modulate thyroid hormone activity, resulting in modified systemic physiological effects.


Enzyme-Mediated Hormone Synthesis Suppression

Propyl-Thiocil acts within the domain of thyroid peroxidase (TPO)-mediated signaling. TPO is an enzyme within the thyroid gland that catalyzes the necessary steps to form the precursor molecules for thyroxine (T4) and triiodothyronine (T3). By inhibiting TPO, the drug suppresses these early molecular steps, modifying the signaling sequence that influences systemic hormone levels.


Peripheral T4 to T3 Conversion Modulation

The drug also modulates key pathways associated with the metabolism of circulating thyroid hormones. It acts as an inhibitor of the enzyme 5'-deiodinase (Type I), which is critical for converting the hormone T4 into its more biologically active form, T3, in peripheral tissues. Diminishing this conversion rate adjusts the overall impact of active hormone within peripheral systems.

Dosage and Administration Information

How to Use Propyl-Thiocil

Propyl-Thiocil (Propylthiouracil) is administered exclusively as oral tablets. The method of use is defined by distinct phases: an initial high-dose phase followed by a lower maintenance phase, with required adjustments for specific patient populations.


Official Administration Guidelines

Feature Guideline
Route of Administration Oral tablets for systemic use.
Initial Adult Dosing Typically 300 mg daily administered in three equally divided doses. Doses may be increased up to 900 mg daily in severe cases.
Maintenance Dosing Ranges from 50 mg to 150 mg daily once a stable state is achieved.
Frequency in Initial Phase Divided into approximately 8-hour intervals to ensure consistent drug levels.
Missed Dose If a dose is missed, it is typically taken as soon as remembered unless the next dose is imminent, in which case the missed dose is skipped; doses are not doubled.
Tablet Intake Tablets are swallowed whole and are typically taken with a copious amount of water.

Population and Course Duration

Dose Adjustment for Organ Impairment: Established protocols require cautious dose selection and reduction for patients with impaired renal or hepatic function. For instance, those with severe renal impairment may use 50% of the standard daily dose.

Use During Pregnancy: Administration during the first trimester is restricted to the lowest possible effective dose with close monitoring.

Total Course Protocol: The high initial dose is maintained until the patient reaches a euthyroid state, usually requiring one to two months. Definitive maintenance therapy often continues for one to two years before discontinuation is considered.

This protocol defines a long-term course of therapy based on close monitoring of thyroid function levels and requires adherence to timing and dosage adjustments throughout the treatment duration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Propyl-Thiocil

Evidence for Managing Primary Hyperthyroidism

Research into Propyl-Thiocil (Propylthiouracil) primarily utilized Randomized Controlled Trials (RCTs) and various observational studies for conditions like Graves' disease and general hyperthyroidism. Researchers mainly examined the changes in hormone biomarker levels, such as the TSH and free T4 in the blood, as a way of measuring physiological change.

Studies monitored the hormone biomarkers and reported patterns observed across the measured timeframes. Evidence consistency varies across studies. Several comparative RCTs were conducted with modest sample sizes. This highlights that results apply only to the populations studied and that comparative evidence is lacking in large, consistent trial designs.


Evidence for Specialized or Acute Clinical Scenarios

Research in this area was observed in Comparative Effectiveness Studies for Thyrotoxic Crisis, an acute health episode. These studies monitored endpoints such as in-hospital mortality and discharge status and the need for organ support. Findings indicate that, in these settings, data show patterns related to measured changes in active thyroid hormone levels. However, because this evidence comes largely from observational settings, evidence quality varies compared to prospective randomized trials for critical outcomes.

Specific Randomized Clinical Trials were conducted to examine Propyl-Thiocil was evaluated in the context of pretreatment before definitive therapy such as radioactive iodine. Research describes that pretreatment was associated with patterns that included differences in the success rate of the subsequent radioactive iodine procedure, which contributes to a specific uncertainty.


Evidence in Special Populations

Research was evaluated in pregnant women due to the unique clinical context of hyperthyroidism during pregnancy. The evidence for this context is summarized through Systematic Reviews and Meta-analyses that combine data from multiple cohort studies. This research examined outcomes related to maternal thyroid hormone stability and also focused on neonatal endpoints, including the reported frequency of congenital anomalies and newborn thyroid function.


Limitations and Unanswered Questions in the Research

Research describes several limitations in the overall evidence for Propyl-Thiocil. For many indications, the sample sizes were modest, meaning that the results apply only to the populations studied. A key uncertainty lies in the comparative evidence, which is sometimes lacking or has mixed findings against alternative agents. Finally, data are still emerging, and long-term effects are not fully established, particularly concerning outcomes spanning multiple years after treatment has stopped.

Key Studies & References

  1. The Differential Effects of Propylthiouracil and Methimazole as Graves' Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial (2022)

Frequently Asked Questions (FAQ)

Common questions about Propyl-Thiocil (FAQ)


Q: How long does it typically take for Propyl-Thiocil to start working?

According to the official product information, the initial onset of action is generally observed between one and three weeks after starting therapy. Full stable euthyroid state typically takes longer to achieve.


Q: How does Propyl-Thiocil affect the liver or kidney function?

Regulatory documents highlight that Propyl-Thiocil carries a risk of severe hepatic (liver) injury. The drug is primarily metabolized by the liver and excreted by the kidneys. Rare cases of renal (kidney) adverse effects have been reported, and the product label notes that dose reduction is necessary for patients with known kidney impairment.


Q: What is the risk of an allergic reaction to Propyl-Thiocil?

Allergic skin reactions, such as rash, hives (urticaria), and itching (pruritus), are listed as common adverse effects, affecting less than 5% of patients in clinical trials. Regulatory guidance states that the medicine is typically stopped if a severe reaction is suspected.


Q: Are there long-term health concerns associated with using Propyl-Thiocil?

Official information indicates that potential long-term concerns include the development of drug-induced lupus erythematosus and the occurrence of hypothyroidism (low thyroid function). Patients undergoing long-term treatment are closely monitored for these changes.


Q: Can Propyl-Thiocil be used by women who are pregnant or breastfeeding?

Use during pregnancy is subject to specific regulatory guidelines. Regarding breastfeeding, the medicine is known to pass into human milk. The product label advises against use during lactation due to the potential for serious adverse reactions in the infant.


Q: Is it normal to feel a change in symptoms immediately after starting Propyl-Thiocil?

Noticeable symptomatic improvement is typically not expected immediately. Official information describes that because the medicine does not block the effect of the thyroid hormone already in the body, it may take several weeks of consistent use to feel the full benefit.


Q: How long does Propyl-Thiocil stay in your system?

Propyl-Thiocil has a short measured plasma half-life of approximately one to two hours. However, its biological effect of suppressing thyroid hormone production persists in the body for a longer duration than the measured blood levels.


Q: Does Propyl-Thiocil cause weight gain or weight loss?

The drug is associated with a risk of developing hypothyroidism (low thyroid function) as an adverse outcome. The development of hypothyroidism can, in turn, lead to side effects like weight gain. The risk of hypothyroidism necessitates regular monitoring of thyroid levels.


Q: Do the side effects of Propyl-Thiocil usually go away over time?

The resolution time frame for most common side effects is not specified in the official labeling. Official guidelines advise patients to inform their healthcare provider if less serious adverse effects, such as rash or nausea, persist or worsen.


Q: Is Propyl-Thiocil known to cause mood changes or depression?

Cases of psychiatric disorders, including symptoms like confusion or anxiety, have been reported rarely in official regulatory data. There is no specifically established or commonly listed data regarding depression as a direct side effect of the medicine.


Q: Does Propyl-Thiocil affect sleep patterns or cause insomnia?

Yes, official prescribing information lists both drowsiness and insomnia (difficulty sleeping) as uncommon side effects associated with this medication.


Q: Can I drink alcohol while taking Propyl-Thiocil?

Regulatory text does not indicate a known specific interaction with alcohol. Caution is generally described in regulatory texts, and consulting a healthcare provider about alcohol use is important due to the drug's potential for hepatic effects.


Q: Are there specific vitamins or supplements that interact with Propyl-Thiocil?

While no specific vitamins are listed, official labeling warns against concurrent use with iodine-containing products, as the iodine content may interfere with the medicine's effectiveness. This includes supplements that contain iodine.


Q: What foods or beverages should be avoided when taking Propyl-Thiocil?

According to official drug information, the tablets can be taken with or without food. There are no known specific restrictions on common foods or beverages, other than those containing high amounts of iodine.


Q: Does Propyl-Thiocil interact with birth control pills or hormone therapy?

Propyl-Thiocil modifies thyroid hormone levels, which can, in turn, influence the metabolism of other external hormones. While this potential exists, the official interaction table does not note a specific contraindication for oral contraceptives.


Q: Can Propyl-Thiocil affect blood pressure levels?

Official documents list adverse effects on heart rhythm and rate, such as tachycardia (a fast heart rate). Changes in these cardiac parameters may secondarily affect blood pressure levels.


Q: Is Propyl-Thiocil available generically?

Yes, the active substance is Propylthiouracil. According to official product information, the drug is available under its generic name.


Q: Is Propyl-Thiocil known to cause physical or psychological dependence?

Official labeling confirms that Propyl-Thiocil is not reported to cause physical or psychological dependence and has no known potential for abuse.


Q: Does Propyl-Thiocil affect my ability to drive or operate machinery?

Due to uncommon side effects such as dizziness and drowsiness, official product information notes that caution is necessary when driving or operating machinery.


Q: Is Propyl-Thiocil a controlled substance?

No, regulatory agencies classify Propyl-Thiocil as a non-controlled substance under the Controlled Substances Act (CSA).

How should Propyl-Thiocil be stored and disposed of?

Propylthiouracil (Propyl-Thiocil) must be stored and disposed of by strictly following official regulatory instructions to ensure product stability and safety.

Storage Requirements

The medicine is required to be stored at Controlled Room Temperature, typically defined as 20 C to 25 C (68 F to 77 F), with temporary excursions permitted up to 30 C. The official label mandates that the tablets be protected from both light and moisture to maintain stability.

The container must be kept tightly closed, and the product must be stored in the original container. It is a mandatory handling requirement that the medicine must not be frozen.

Disposal and Safety

For safety, Propylthiouracil must be stored out of the sight and reach of children.

Disposal of unused or expired tablets must occur in accordance with local requirements for pharmaceutical waste, as directed by regulatory agencies. Consultation with a pharmacist or healthcare professional regarding specific disposal methods for unused medicine is advised.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Propyl-Thiocil found in:

A-Z Index: